248.616.001 Boehringer Ingelheim Investigational Site

Minneapolis, Minnesota

0 studies enrolling now · 1 studies all time

What they study most

Restless Legs Syndrome

Studies at this site

• A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS — Completed